US5364632A
(en)
*
|
1989-04-05 |
1994-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Medicinal emulsions
|
ZA927277B
(en)
*
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
EP0733918B1
(de)
*
|
1995-03-24 |
2003-07-30 |
Ocular Research of Boston, Inc. |
Hydrogellinse mit Lipid-Vorbeschichtigung
|
DE19511322C2
(de)
|
1995-03-28 |
1999-09-02 |
Mann Gerhard Chem Pharm Fab |
Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
|
US5616342A
(en)
*
|
1995-04-11 |
1997-04-01 |
Pdt, Inc. |
Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
|
DE19527132A1
(de)
*
|
1995-07-25 |
1997-01-30 |
Laevosan Gmbh & Co Kg |
Ophthalmologische Ozonschutzzusammensetzung
|
US5696166A
(en)
*
|
1995-10-31 |
1997-12-09 |
Yanni; John M. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
JPH10218760A
(ja)
*
|
1997-02-04 |
1998-08-18 |
Nobel Igaku Kenkyusho:Kk |
ドライアイ治療用の微量油添加目薬
|
ZA989513B
(en)
|
1997-10-21 |
1999-04-21 |
Alcon Lab Inc |
Compositions containing histamine H2 agonists and methods of use in treating dry eye
|
RU2125427C1
(ru)
*
|
1998-05-27 |
1999-01-27 |
Миронова Эмилия Михайловна |
Средство для лечения глазных заболеваний - оковидит
|
EP0982025A1
(de)
*
|
1998-08-28 |
2000-03-01 |
Wilhelm Prof. Dr. Stoffel |
Künstliche Tränen
|
US6462080B1
(en)
|
1998-12-24 |
2002-10-08 |
Alcon Manufacturing, Ltd. |
Prostaglandin E receptor agonists for treatment of dry eye
|
AU2183900A
(en)
|
1998-12-24 |
2000-07-31 |
Alcon Laboratories, Inc. |
Ep4 receptor agonists for treatment of dry eye
|
US6281192B1
(en)
|
1999-03-01 |
2001-08-28 |
Vista Scientific Llc |
Mucin containing ophthalmic preparations
|
AUPQ228199A0
(en)
*
|
1999-08-18 |
1999-09-09 |
Sly, Anthony William |
Ophthalmic fluid
|
TR200201251T2
(tr)
|
1999-11-09 |
2002-11-21 |
Alcon, Inc. |
Omega zinciri tadil edilmiş 15-hidroksieikosatetraenoik asit türevleri ve bunların göz kurumasının iyileştirilmesi için kullanım yöntemleri
|
US6353032B1
(en)
|
1999-11-09 |
2002-03-05 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
US6803385B2
(en)
|
1999-11-09 |
2004-10-12 |
Alcon, Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
CA2386636A1
(en)
|
1999-11-09 |
2001-05-17 |
Alcon, Inc. |
15-hydroxyeicosatetraenoic acid-related compounds and methods of use
|
PT1228027E
(pt)
|
1999-11-09 |
2004-08-31 |
Alcon Inc |
Derivados de 15-hete com heteroatomo substituinte em posicao 3 e homologos com dois carbonos e metodos de utilizacao
|
WO2001034550A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
|
WO2001034553A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
|
US6552084B2
(en)
|
1999-11-09 |
2003-04-22 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
US6458854B2
(en)
|
1999-11-09 |
2002-10-01 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
AU776153B2
(en)
|
1999-11-09 |
2004-08-26 |
Alcon Inc. |
Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
|
US6645978B1
(en)
|
1999-11-09 |
2003-11-11 |
Alcon, Inc. |
Lipoxin A4 and its analogs for the treatment of dry eye
|
PT1227809E
(pt)
|
1999-11-09 |
2005-06-30 |
Alcon Inc |
Analogos do acido 15-hidroxieicosatetraenoico interrompidos por um heteroatomo e metodos de utilizacao
|
BR0015436A
(pt)
|
1999-11-09 |
2002-07-16 |
Alcon Inc |
Sais de hidroxieicosatetraenoato, composições e métodos de uso no tratamento de distúrbios dos olhos secos
|
DK1228032T3
(da)
|
1999-11-09 |
2004-11-01 |
Alcon Inc |
Præparater, som indeholder hydroxyicosatetraensyrederivater, og fremgangsmåder til anvendelse ved behandling af öjentörhedslidelser
|
US6576663B2
(en)
|
1999-12-22 |
2003-06-10 |
Alcon, Inc. |
6-Keto prostaglandin F1α and analogs for treating dry eye
|
US6348508B1
(en)
|
2000-04-04 |
2002-02-19 |
Bausch & Lomb Incorporated |
Method for treating dry eye
|
US7524511B1
(en)
*
|
2000-07-12 |
2009-04-28 |
Rogue Valley Natural Springs, Inc. |
Method and kit for moisturizing the surface of the eye
|
IL153892A0
(en)
*
|
2000-07-12 |
2003-07-31 |
Rogue Valley Natural Springs I |
Method and kit for moisturizing the surface of the eye
|
JP2004527578A
(ja)
|
2001-05-21 |
2004-09-09 |
アルコン,インコーポレイテッド |
ドライアイ障害を処置するためのNF−κBインヒビターの使用
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
WO2002094311A1
(en)
|
2001-05-21 |
2002-11-28 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
JP2004531560A
(ja)
*
|
2001-05-21 |
2004-10-14 |
アルコン,インコーポレイテッド |
ドライアイ障害を処置する方法
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
FR2827190A1
(fr)
*
|
2001-06-22 |
2003-01-17 |
Rhodia Chimie Sa |
Utilisation d'une huile comprenant un groupement polaire comme aide au depot d'une huile polaire non ionisable
|
US6750250B1
(en)
*
|
2001-07-12 |
2004-06-15 |
Alcon, Inc. |
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
|
DE10141018A1
(de)
*
|
2001-08-22 |
2003-03-13 |
Eth Zuerich Eidgenoessische Te |
Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
JP2005505592A
(ja)
*
|
2001-10-11 |
2005-02-24 |
アルコン,インコーポレイテッド |
抗炎症性ステロイドとmuc−1分泌促進薬との組み合わせによる、ドライアイを処置するための方法
|
WO2003030894A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
US6656460B2
(en)
*
|
2001-11-01 |
2003-12-02 |
Yissum Research Development |
Method and composition for dry eye treatment
|
AU782913B2
(en)
*
|
2001-11-02 |
2005-09-08 |
Santen Sas |
Method and composition for dry eye treatment
|
CA2484512C
(en)
*
|
2002-05-17 |
2013-04-16 |
Othera Pharmaceuticals, Inc. |
Treatment of cataracts and other ophthalmic diseases
|
BR0314603A
(pt)
*
|
2002-09-20 |
2005-07-26 |
Alcon Inc |
Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
|
WO2004060274A2
(en)
*
|
2002-12-20 |
2004-07-22 |
Alcon, Inc. |
Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
|
US7235556B2
(en)
|
2003-04-16 |
2007-06-26 |
Alcon, Inc. |
Methods of treating dry eye disorders
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
CN100464786C
(zh)
*
|
2003-09-10 |
2009-03-04 |
千寿制药株式会社 |
隐形眼镜用眼科用组合物
|
MXPA03011987A
(es)
|
2003-12-19 |
2005-06-23 |
Osio Sancho Alberto |
Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
|
US20070082017A1
(en)
*
|
2004-01-10 |
2007-04-12 |
Tseng Scheffer C |
Lipid compositions and methods of use
|
US20050182039A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Bausch & Lomb Incorporated |
Use of Loteprednol etabonate for the treatment of dry eye
|
CA2560824A1
(en)
|
2004-03-25 |
2005-10-13 |
Bausch & Lomb Incorporated |
Use of loteprednol etabonate for the treatment of dry eye
|
MXPA06013170A
(es)
*
|
2004-05-14 |
2007-02-13 |
Alcon Inc |
Metodo para tratar trastornos de queratoconjuntivitis seca y uveitis.
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
WO2006007510A1
(en)
*
|
2004-07-01 |
2006-01-19 |
Schepens Eye Research |
Compositions and methods for treating eye disorders and conditions
|
JP5272307B2
(ja)
*
|
2004-07-16 |
2013-08-28 |
大正製薬株式会社 |
水性点眼剤
|
US7223737B1
(en)
|
2004-08-13 |
2007-05-29 |
Alcon, Inc. |
Method of treating dry eye disorders using glycosides
|
JPWO2006022291A1
(ja)
*
|
2004-08-27 |
2008-05-08 |
千寿製薬株式会社 |
ドライアイ治療用点眼液
|
WO2006065916A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(s)-hode and its analogs
|
AU2012201476B2
(en)
*
|
2005-01-12 |
2014-07-17 |
Ocular Research Of Boston, Inc |
Dry eye treatment
|
US9161905B2
(en)
*
|
2005-01-12 |
2015-10-20 |
Ocular Research Of Boston, Inc. |
Dry eye treatment
|
TWI393567B
(zh)
*
|
2005-03-31 |
2013-04-21 |
Bausch & Lomb |
治療乾眼之組合物及相關之製造方法及使用方法
|
TW200722109A
(en)
*
|
2005-03-31 |
2007-06-16 |
Bausch & Lomb |
Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
|
DK1888059T3
(en)
|
2005-06-01 |
2015-03-30 |
Edison Pharmaceuticals Inc |
Redox-active therapeutic products for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers
|
WO2007005421A2
(en)
*
|
2005-07-01 |
2007-01-11 |
Bausch & Lomb Incorporated |
Long lasting alginate dry eye, related methods of manufacture and methods of use
|
US20070110812A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Bausch & Lomb Incorporated |
Ophthalmic composition for dry eye therapy
|
JP6033177B2
(ja)
*
|
2006-01-13 |
2016-11-30 |
大正製薬株式会社 |
O/w型エマルション水性点眼剤
|
JP5748385B2
(ja)
*
|
2006-01-13 |
2015-07-15 |
大正製薬株式会社 |
O/w型エマルション水性点眼剤
|
JP5374162B2
(ja)
|
2006-02-22 |
2013-12-25 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
|
US7745461B1
(en)
|
2006-02-27 |
2010-06-29 |
Alcon Research, Ltd. |
Method of treating dry eye disorders
|
ES2284398B2
(es)
|
2006-04-27 |
2008-12-16 |
Universidad Complutense De Madrid |
Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
|
US7691811B2
(en)
*
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
JP2009542704A
(ja)
*
|
2006-07-07 |
2009-12-03 |
ボーシュ アンド ローム インコーポレイティド |
ドライ・アイを治療するための医薬組成物と方法
|
US20080057022A1
(en)
*
|
2006-08-30 |
2008-03-06 |
Erning Xia |
Ophthalmic Pharmaceutical Compositions and Uses Thereof
|
US20080095754A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Burke Susan E |
Ophthalmic compositions comprising diglycine
|
US8138156B2
(en)
*
|
2006-10-18 |
2012-03-20 |
Bausch & Lomb Incorporated |
Ophthalmic compositions containing diglycine
|
US20080093247A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Alcon Manufacturing Ltd. |
Packaging materials for formulations containing 2-pyrrolidone derivatives
|
WO2008052031A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Alcon Research, Ltd. |
2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
|
US20080188573A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Alcon Research, Ltd. |
Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
|
WO2008120249A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Sifi S.P.A. |
Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
|
EP2155162B1
(de)
*
|
2007-05-04 |
2012-11-21 |
Bausch & Lomb Incorporated |
Zusammensetzungen zur reduzierung, linderung, behandlung oder verhütung von trockenen augen und verfahren zu ihrer herstellung und verwendung
|
CA2686866A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Erning Xia |
Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
|
WO2008154129A1
(en)
*
|
2007-06-08 |
2008-12-18 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
|
US20090142292A1
(en)
*
|
2007-12-03 |
2009-06-04 |
Blackwell Richard I |
Method For The Mitigation of Symptoms of Dry Eye
|
US8629099B2
(en)
*
|
2008-03-25 |
2014-01-14 |
Bausch & Lomb Incorporated |
Ophthalmic compositions comprising a dipeptide
|
WO2010030607A1
(en)
|
2008-09-10 |
2010-03-18 |
Edison Pharmaceuticals, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
US20110195927A1
(en)
*
|
2008-09-15 |
2011-08-11 |
Compositions Comprising Polymers Having Aminio Sugar Unites And Methods Of Making And Using Same |
Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same
|
US8539938B2
(en)
*
|
2009-03-12 |
2013-09-24 |
Ford Global Technologies, Llc |
Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
|
MX336800B
(es)
|
2009-04-28 |
2016-02-02 |
Edison Pharmaceuticals Inc |
Tratamiento de neuropatia optica hereditaria de leber y atrofia optica dominante con tocotrienol quinonas.
|
TWI478730B
(zh)
*
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
US8658614B2
(en)
|
2010-08-13 |
2014-02-25 |
The University of Texas Health Science Center |
Aptamer-containing compositions and methods for targeting E-selectin
|
US9161531B2
(en)
|
2011-02-23 |
2015-10-20 |
Donald R. Korb |
High alcohol content sanitizer
|
US8859525B2
(en)
|
2011-07-19 |
2014-10-14 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
|
AU2012312816A1
(en)
|
2011-09-22 |
2014-04-24 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
US8324171B1
(en)
|
2012-02-06 |
2012-12-04 |
Bausch & Lomb Incorporated |
Ophthalmic compositions containing diglycine
|
US8664180B2
(en)
|
2012-02-06 |
2014-03-04 |
Bausch & Lomb Incorporated |
Ophthalmic compositions containing diglycine
|
US9278132B2
(en)
|
2012-02-13 |
2016-03-08 |
Bausch & Lomb Incorporated |
Ophthalmic pharmaceutical compositions and methods of making and using same
|
MX350201B
(es)
|
2012-02-24 |
2017-08-30 |
Bausch & Lomb |
Composiciones oftalmicas con ceras alcoxiladas naturales.
|
JP6016465B2
(ja)
*
|
2012-06-12 |
2016-10-26 |
ロート製薬株式会社 |
ビタミンa類を含有する水性組成物
|
KR102114111B1
(ko)
|
2012-08-10 |
2020-05-25 |
오시오 코포레이션 디/비/에이 율리아 헬스 |
안과적 상태 치료시의 컨택트 렌즈 사용
|
JP6290929B2
(ja)
|
2013-01-24 |
2018-03-07 |
ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated |
アルコキシル化天然ワックスを有する眼用組成物
|
JP6612247B2
(ja)
|
2014-03-12 |
2019-11-27 |
ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン |
眼の感染症および疾患を処置するための組成物および方法
|
CA2947741A1
(en)
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
CA2951923A1
(en)
|
2014-06-18 |
2015-12-23 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of active agents
|
JP7002756B2
(ja)
|
2015-11-05 |
2022-01-20 |
ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション,インコーポレーテッド |
局所と局部の麻酔と鎮痛
|
EP3389646A1
(de)
|
2015-12-17 |
2018-10-24 |
BioElectron Technology Corporation |
Flouralkyl, flouralkoxy, phenoxy, heteroaryloxy, alkoxy und amin-1,4-benzochinon-derivate zur behandlung von oxidativen stresserkrankungen
|
US10130719B2
(en)
|
2016-06-03 |
2018-11-20 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to salts of specialized pro-resolving mediators
|
US9981041B2
(en)
|
2016-08-23 |
2018-05-29 |
Ira Jason Salzman |
Ophthalmic lubricating spray
|
US20180296390A1
(en)
*
|
2017-04-18 |
2018-10-18 |
David Hoare |
Apparatus and method for treating a number of eye conditions of a user including dry eye syndrome and/or burns to the eyes
|
TW201938141A
(zh)
|
2018-02-21 |
2019-10-01 |
瑞士商諾華公司 |
基於脂質的眼用乳劑
|
US11147736B2
(en)
|
2018-02-26 |
2021-10-19 |
Olympic Ophthalmics, Inc. |
Therapeutic handheld devices for disorders
|
JP2022510735A
(ja)
|
2018-12-10 |
2022-01-27 |
エテルナティアー インコーポレイテッド |
長続きする眼の潤滑をもたらす眼用配合物
|
US11471475B1
(en)
|
2022-03-08 |
2022-10-18 |
Ralph P. Stone |
Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
|
US11679078B1
(en)
|
2022-03-08 |
2023-06-20 |
EternaTear, Inc. |
Ophthalmic formulations and related methods
|